Navigation Links
Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
Date:5/17/2010

LAIYANG, China, May 17 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for the third quarter fiscal year 2010 ended March 31, 2010.

    Third Quarter Highlights

    -- Revenue was $25.6 million, a slight decrease of 0.6% year-over-year
    -- Gross profit was $18.6 million, as compared to $18.9 million, and gross
       margin was 72.7%, as compared to 73.4% in the year ago quarter
    -- Operating income rose 3.1% to $13.7 million
    -- GAAP net income was $15.2 million, or $1.33 per basic share, compared
       $8.9 million or $0.86 per basic share a year ago
    -- Excluding loss from discontinued operation, non-cash gain or loss
       related to the change in fair value of derivative liabilities,
       unrealized gain or loss on trading securities, and amortization
       expenses for debt discount and financing cost, non-GAAP adjusted net
       income was $7.7 million, or $0.50 per diluted share, as compared to
       non-GAAP adjusted net income of $10.1 million, or $0.68 per diluted
       share.

"Our third quarter operating income returned to growth as a result of strengthened sales effort and improved operational efficiency stemming from our continued cost control efforts," said Jiangbo's Chairman and CEO, Mr. Wubo Cao. "Sales of several of our key products, including Clarithromycin sustained-release and Radix Isatidis, experienced strong year-over-year growth and reflected the recent reinforcement of our sales effort and distribut
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
2. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
3. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
4. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
5. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
6. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
7. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
8. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
9. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
10. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
11. Jazz Pharmaceuticals Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... PASADENA, Calif. , March 26, 2015 ... San Gabriel Valley to perform transcatheter aortic valve replacement ... TAVR procedure is a revolutionary new way to replace ... use of a heart lung machine. The ... heart team led by Azhil ( Alex) Durairaj , ...
(Date:3/26/2015)... VANCOUVER, British Columbia, March 26, 2015  OncoGenex ... a summary of clinical developments and announced fourth ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... and Teva agreed to negotiate the termination of ... Negotiations of the final termination agreement are ongoing. ...
(Date:3/26/2015)... According to a new market ... (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, Oncology), ... - Global Forecasts to 2019", published by MarketsandMarkets, the ... Million growing at a CAGR of 11.50% by 2019. ... figures spread through 195 pages and in-depth TOC on ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4
... 2011 GlaxoSmithKline (GSK) is committed to ensuring that ... and alli. alli is safe and effective when used ... and works locally in the gastro-intestinal tract. GSK continues ... share all relevant information with regulatory agencies. ...
... April 14, 2011 Freedom Innovations, a company ... lower extremity prosthetic devices, today announced a worldwide ... rights to commercialize the world,s first lower extremity ... that operate synergistically.  Developed at the Vanderbilt University ...
Cached Medicine Technology:Freedom Innovations to Commercialize the World's First Actively-Powered, Complete Lower Extremity Prosthesis 2Freedom Innovations to Commercialize the World's First Actively-Powered, Complete Lower Extremity Prosthesis 3
(Date:3/26/2015)... Behavioral Research Group, LLC , a ... of BathroomMap® , a new bathroom finder app ... restrooms for travelers, especially those with medical conditions. Contrary ... facilitate a paid, social or crowdsourced model, but rather ... establishments that have clean, available restrooms in any given ...
(Date:3/26/2015)... Saving Moses is a global humanitarian ... needed but least available. As one of their staple ... in the Benguela province of Angola to treat babies ... visit to their clinics, staff employed the art of ... babies in a nation the The New York Times ...
(Date:3/26/2015)... Tarrytown, NY (PRWEB) March 26, 2015 ... conducted its 30th “Introduction to Hyperbaric Medicine” course, ... Hyperbaric Medical Society (UHMS) and the National Board ... LST provides the 40-hour course 4 times a ... facilities around the NY tri-state region; registration is ...
(Date:3/26/2015)... 2015 BioPlus Specialty Pharmacy ... specialty pharmacies, announces the promotion of Sharon Ferrer ... of Pharmaceutical Relations. In this position, Ferrer will ... pharmaceuticals partners and providing key leadership in building ... expansion. , “Over the past seven years ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... the Patients’ Access to Treatments Act (PATA) that ... week by Reps. David B. McKinley (R-WV) and ... limit cost-sharing requirements for medications placed in a ... by reducing patients’ out-of-pocket expenses. , This legislation ...
Breaking Medicine News(10 mins):Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2
... 17 The Juvenile,Products Manufacturers Association (JPMA), which ... United States, stands by the,scientific research indicating that ... scientific evaluation process of the National,Toxicology Program,s (NTP) ... Following an expert panel review last year, this ...
... March of Dimes E-Card, WHITE PLAINS, N.Y., April 17 ... available free and exclusively,from the March of Dimes., The e-card, ... uploading Mom,s photo - or maybe a photo of yourself or ... The card portrays Mom in her rightful positions -- star of ...
... the menu or not, the American Diabetes Association,provides tips for ... quiz -- which,has more calories -- a tuna salad sandwich ... learn the tuna fish salad normally has at least,twice the ... daily diet?,And how many calories a day are you supposed ...
... noninvasive cholesterol test, study shows , , THURSDAY, April 17 (HealthDay ... a small sample of skin cells scraped off the palm ... in healthy people, researchers report. , The test looks at ... , In a test on 9,055 people, skin sterol readings ...
... are more likely to punish their teen,s risky behavior ... by a desire to set a strict example for ... University of Maryland, Duke University and The Johns Hopkins ... to predict levels of parental discipline. Parental concern for ...
... (Nasdaq: DYNT ) today announced the introduction ... for treating back pain and the,Dynatron X5 "Turbo" ... Spinal Health System uses a four-phase treatment,regimen combining ... and nutrition," said Larry K. Beardall,executive vice president ...
Cached Medicine News:Health News:Juvenile Products Manufacturers Association Supports Safety of Baby Bottles 2Health News:Mom You Rock! 2Health News:What You Don't Know Could Hurt You 2Health News:What You Don't Know Could Hurt You 3Health News:Skin Test Spots Heart Risks in Healthy People 2Health News:Parents stricter with older kids to set example: game theory study 2Health News:Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo' 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: